TY - JOUR
T1 - Disparities in Thyroid Cancer Diagnosis Based on Residence and Distance From Medical Facility
AU - Regmi, Sunita
AU - Farazi, Paraskevi A.
AU - Lyden, Elizabeth
AU - Kotwal, Anupam
AU - Ganti, Apar Kishor
AU - Goldner, Whitney
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the Endocrine Society.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Context: Rural-urban disparities have been reported in cancer care, but data are sparse on the effect of geography and location of residence on access to care in thyroid cancer. Objective: To identify impact of rural or urban residence and distance from treatment center on thyroid cancer stage at diagnosis. Methods: We evaluated 800 adults with differentiated thyroid cancer in the iCaRe2 bioinformatics/biospecimen registry at the Fred and Pamela Buffett Cancer Center. Participants were categorized into early and late stage using AJCC staging, and residence/distance from treating facility was categorized as short (12.5miles), intermediate (12.5 to 50 miles) or long (50miles). Multivariable logistic regression was used to identify factors associated with late-stage diagnosis. Results: Overall, 71% lived in an urban area and 29% lived in a rural area. Distance from home to the treating facility was short for 224 (28%), intermediate for 231 (28.8%), and long for 345 (43.1%). All 224 (100%) short, 226 (97.8%) intermediate, and 120 (34.7%) long distances were for urban patients; in contrast, among rural patients, 5 (2.16%) lived intermediate and 225 (65.2%) lived long distances from treatment (P <. 0001). Using eighth edition AJCC staging, the odds ratio of late stage at diagnosis for rural participants ≥ 55 years was 2.56 (95% CI, 1.08-6.14) (P =. 03), and for those living ≥ 50 miles was 4.65 (95% CI, 1.28-16.93) (P =. 0075). Results were similar using seventh edition AJCC staging. Conclusion: Older age at diagnosis, living in rural areas, and residing farther from the treatment center are all independently associated with late stage at diagnosis of thyroid cancer.
AB - Context: Rural-urban disparities have been reported in cancer care, but data are sparse on the effect of geography and location of residence on access to care in thyroid cancer. Objective: To identify impact of rural or urban residence and distance from treatment center on thyroid cancer stage at diagnosis. Methods: We evaluated 800 adults with differentiated thyroid cancer in the iCaRe2 bioinformatics/biospecimen registry at the Fred and Pamela Buffett Cancer Center. Participants were categorized into early and late stage using AJCC staging, and residence/distance from treating facility was categorized as short (12.5miles), intermediate (12.5 to 50 miles) or long (50miles). Multivariable logistic regression was used to identify factors associated with late-stage diagnosis. Results: Overall, 71% lived in an urban area and 29% lived in a rural area. Distance from home to the treating facility was short for 224 (28%), intermediate for 231 (28.8%), and long for 345 (43.1%). All 224 (100%) short, 226 (97.8%) intermediate, and 120 (34.7%) long distances were for urban patients; in contrast, among rural patients, 5 (2.16%) lived intermediate and 225 (65.2%) lived long distances from treatment (P <. 0001). Using eighth edition AJCC staging, the odds ratio of late stage at diagnosis for rural participants ≥ 55 years was 2.56 (95% CI, 1.08-6.14) (P =. 03), and for those living ≥ 50 miles was 4.65 (95% CI, 1.28-16.93) (P =. 0075). Results were similar using seventh edition AJCC staging. Conclusion: Older age at diagnosis, living in rural areas, and residing farther from the treatment center are all independently associated with late stage at diagnosis of thyroid cancer.
KW - access to care
KW - disparities
KW - presentation
KW - thyroid cancer
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85188148571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85188148571&partnerID=8YFLogxK
U2 - 10.1210/jendso/bvae033
DO - 10.1210/jendso/bvae033
M3 - Article
C2 - 38481601
AN - SCOPUS:85188148571
SN - 2472-1972
VL - 8
JO - Journal of the Endocrine Society
JF - Journal of the Endocrine Society
IS - 5
M1 - bvae033
ER -